News & Articles 26/06/2023 Our Network Soliris recommended for approval in the EU by CHMP for children and adolescents with refractory generalised myasthenia gravis (gMG) Potential approval for Soliris would mark first and only targeted treatment for this patient population in the European Union.
News & Articles 17/06/2023 Our Network Real-world evidence study shows the significant impact of hyperkalaemia on cardiorenal patient outcomes AstraZeneca’s real-world evidence (RWE) ZORA study shows the negative consequences of reducing or discontinuing life-saving renin-angiotensin-aldosterone system inhibitor (RAASi) medication in patients experiencing hyperkalaemia (HK).
News & Articles 13/06/2023 Our Network TrailblAZers in Oncology: Moving mountains for patients As a hematologist, your patients trust you with their lives.
